Review
Application and progress of ablation therapy for large liver cancer
Wang Zhen, Wang Zhen, Wang Shuo, Zhang Yiqiong, Yu Xiaoling
Published 2024-05-20
Cite as Chin J Hepatol, 2024, 32(5): 469-473. DOI: 10.3760/cma.j.cn501113-20230926-00123
Abstract
Primary liver cancer is one of the most common malignant tumors. A liver tumor is defined as a large cancer when its diameter is ≥5 cm. Resection surgical therapy can be performed only on a small portion of large cancers because of its own features. As a result, non-resection surgical therapy has become a hot and difficult issue of widespread concern. In recent years, with the development of ablation technology, research on the use of ablation alone and ablation combined with other modalities for the treatment of large liver cancer has continued to deepen, and good clinical results have been achieved. Although there are many reports on ablation treatment for large liver cancer, there are currently no standardized treatment guidelines, and there are still controversies about treatment strategies. This article reviews the development of ablation therapy, the current status of single and combined ablation therapy, the prevention of related complications, and other aspects of large liver cancer.
Key words:
Hepatocellular carcinoma; Ablation; Therapeutic; Giant hepatocellular carcinoma; Complications; Review
Contributor Information
Wang Zhen
Department of Interventional Ultrasound, First Medical Center of Chinese PLA General Hospital, Beijing 100039, China
Chinese PLA Medical School, Beijing 100039, China
Wang Zhen
Department of Interventional Ultrasound, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China
Wang Shuo
Department of Interventional Ultrasound, First Medical Center of Chinese PLA General Hospital, Beijing 100039, China
Chinese PLA Medical School, Beijing 100039, China
Zhang Yiqiong
Department of Interventional Ultrasound, First Medical Center of Chinese PLA General Hospital, Beijing 100039, China
Chinese PLA Medical School, Beijing 100039, China
Yu Xiaoling
Department of Interventional Ultrasound, First Medical Center of Chinese PLA General Hospital, Beijing 100039, China